FAM111B and ovarian carcinoma: The downregulation of FAM111B in ovarian cancer cells resulted in a reduction in MYC expression levels; and subsequent rescue experiments revealed that the overexpression of MYC significantly affected the FAM111B phenotype, leading to the restoration of cellular viability, proliferation, migration, and invasion.